We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOPE icon
1276
Hope Bancorp
HOPE
$1.82B
$26K ﹤0.01%
3,482
+1,078
+45% +$9.01K
CUTR
1277
DELISTED
Cutera, Inc.
CUTR
$26K ﹤0.01%
1,365
+170
+14% +$2.63K
BPOP icon
1278
Popular Inc
BPOP
$11.2B
$25K ﹤0.01%
686
-1,060
-61% -$39.3K
HYLN icon
1279
CALL
Hyliion Holdings
HYLN
$699M
$25K ﹤0.01%
+500
New +$16.4K
IQ icon
1280
CALL
iQIYI
IQ
$1.3B
$25K ﹤0.01%
1,100
-1,000
-48% -$21.9K
NKTR icon
1281
Nektar Therapeutics
NKTR
$2.55B
$25K ﹤0.01%
100
-439
-81% -$138K
PEB icon
1282
Pebblebrook Hotel Trust
PEB
$2.01B
$25K ﹤0.01%
1,958
SAIA icon
1283
PUT
Saia
SAIA
$9.52B
$25K ﹤0.01%
200
-1,300
-87% -$166K
SYKE
1284
DELISTED
SYKES Enterprises Inc
SYKE
$25K ﹤0.01%
731
+256
+54% +$7.92K
INWK
1285
DELISTED
InnerWorkings, Inc.
INWK
$25K ﹤0.01%
8,453
+6,246
+283% +$16.1K
AG icon
1286
CALL
First Majestic Silver
AG
$9.35B
$24K ﹤0.01%
+2,500
New +$29.1K
DKNG icon
1287
CALL
DraftKings
DKNG
$12.6B
$24K ﹤0.01%
400
-1,000
-71% -$38.9K
E icon
1288
ENI
E
$80.3B
$24K ﹤0.01%
1,528
+1,076
+238% +$20K
MNK
1289
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$24K ﹤0.01%
25,000
+21,990
+731% +$38.9K
CCMP
1290
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$24K ﹤0.01%
165
-1,555
-90% -$232K
BMRN icon
1291
CALL
BioMarin Pharmaceuticals
BMRN
$13.5B
$23K ﹤0.01%
300
-100
-25% -$10.1K
CBSH icon
1292
Commerce Bancshares
CBSH
$8.47B
$23K ﹤0.01%
+545
New +$23.4K
ERII icon
1293
Energy Recovery
ERII
$394M
$23K ﹤0.01%
2,800
+1,700
+155% +$13.6K
MD icon
1294
Pediatrix Medical
MD
$2.12B
$23K ﹤0.01%
1,433
-2,382
-62% -$44.3K
NTR icon
1295
Nutrien
NTR
$32.1B
$23K ﹤0.01%
590
-407
-41% -$14.8K
SLG icon
1296
SL Green Realty
SLG
$3.95B
$23K ﹤0.01%
506
-2,334
-82% -$108K
TDC icon
1297
CALL
Teradata
TDC
$2.5B
$23K ﹤0.01%
+1,000
New +$22.2K
UCB
1298
United Community Banks
UCB
$4.36B
$23K ﹤0.01%
1,341
+820
+157% +$14.8K
FIT
1299
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$23K ﹤0.01%
3,300
+2,700
+450% +$17.5K
ACGL icon
1300
Arch Capital
ACGL
$33.5B
$22K ﹤0.01%
742
-2,995
-80% -$91.3K

Similar funds

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.